It started with black bears. It was 1999, and University of Minnesota researcher Paul Iaizzo connected with Tim Laske, now vice president of research in Medtronic's cardiac ablation products business.

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population DUBLIN, Sept. 20, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader ...

Medtronic this week received regulatory approval for use of an implantable cardiac monitor in pediatric patients, giving doctors and parents greater peace of mind about the device's safety. On Tuesday ...

After receiving the necessary regulatory approval, Medtronic is launching its latest product on the global market. The medical devices company announced on Wednesday that it has received clearance ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

GAITHERSBURG, Md., March 1 (Reuters) - A U.S. advisory panel voted 9-2 on Thursday against recommending approval of a Medtronic Inc. implantable device that monitors the heart and sends data to ...

Medtronic Plc MDT has recalled certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) with glassed feedthrough. The FDA has identified ...

Parkview Health announced today that its Heart Institute has been selected by medical technology firm Medtronic as one of 65 hospitals globally to participate in a clinical trial of a new heart ...

CathWorks’ Mike Feher has had his plate full since last May when he was honored by the Business Journal with a CFO of the Year Award in the private sector, for helping his company negotiate a $75 ...

The LINQ II ICM is the first continuous, long-term cardiac monitor cleared by FDA for the pediatric patient population The LINQ II system is a small (one-third the size of a AAA battery), wireless ICM ...